Antisense Cancer Therapy: Do Antisense Oligonucleotides Hold Promise as a Cure for Cancer?Mohammad Innus*
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States of America
- *Corresponding Author:
- Mohammad Innus
Department of Biochemistry and Molecular Pharmacology
University of Massachusetts Medical School, 364 Plantation Street
Worcester, Massachusetts 01605, United States of America
E-mail: [email protected]
Received date: May 25, 2017; Accepted date: May 27, 2017; Published date: June 12, 2017
Citation: Innus M (2017) Antisense Cancer Therapy: Do Antisense Oligonucleotides Hold Promise as a Cure for Cancer?. Chem Sci J 8:e117. doi:10.4172/2150-3494.1000e117
Copyright: © 2017 Innus M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Cancer is a dreadful disease causing a major percentage of deaths all over the world. Cancer is the second leading cause of death in the United States, trailing cardiovascular disease. According to National Cancer Institute statistics, over half a million deaths and a million and half new cases are predicted in the year 2017 . The human body is composed of trillions of cells, and they perform specific functions with the aid of proteins. Genes impact the production of these proteins, and an error contained in these genes can yield aberrant versions of these proteins. In some cases, this can result in cancer. A newly diagnosed patient is often concerned for the following reasons: 1) they are afraid of cancer treatments being costly, 2) cancer survival rates are sometimes low and chances of reoccurrence of some cancers are high, and 3) the false paradigm that cancer is incurable.